H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium
Authors:
- 1 May 2004
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 14 (3) , 521-525
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Possible physiological role of H19 RNAMolecular Carcinogenesis, 2002
- Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma.Molecular Pathology, 1998
- Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element.Genes & Development, 1997
- Genomic Imprinting and the Endometrial CycleDiagnostic Molecular Pathology, 1997
- The imprinted H19 gene as a tumor marker in bladder carcinomaUrology, 1995
- Differential expression of messenger ribonucleic acids encoding insulin- like growth factors and their receptors in human uterine endometrium and deciduaThe Journal of Clinical Endocrinology & Metabolism, 1993
- Insulin‐like growth factor binding protein‐1 in female reproductive functionsInternational Journal of Gynecology & Obstetrics, 1992
- Insulin‐like Growth Factor‐II (IGF‐II) and IGF Binding Proteins in Human EndometriumaAnnals of the New York Academy of Sciences, 1991
- Expression of the insulin‐like and platelet‐derived growth factor genes in human uterine tissuesMolecular Reproduction and Development, 1990
- Regulation of uterine insulin-like growth factor I mRNA and insulin-like growth factor II mRNA by estrogen in the ratEuropean Journal of Endocrinology, 1989